
Report of consultations with Member States, partner organizations and non-State actors on Access to Novel Medicines Platform: January–February 2023 / World Health Organization. Regional Office for Europe
Tác giả : World Health Organization. Regional Office for Europe
Nhà xuất bản : World Health Organization. Regional Office for Europe
Năm xuất bản : 2023
Chủ đề : 1. Health Systems Plans. 2. Intersectoral Collaboration. 3. Medicine. 4. Pharmaceutical Services. 5. Public Health. 6. Technical documents.
Thông tin chi tiết
Tóm tắt : | At the 72nd session of the WHO Regional Committee for Europe in Tel Aviv, Israel, in September 2022, the WHO Regional Office for Europe, in agreement with Member States, issued a statement of intent to act as a neutral convenor for the establishment of a platform for collaboration, to agree on solutions and improve patient access to novel high-cost medicines. The Access to Novel Medicines Platform (NMP) will enable Member States, non-State actors and other partners to coordinate, collaborate, prioritize and align efforts to deliver solutions to improve access for patients. The strategic aims, terms of reference and areas of work for the NMP were drafted and refined in three virtual consultations in January and February 2023. The diversity of the markets was noted, as were specific issues for low- and middle-income countries and small markets, as well as challenges with markets for antimicrobials. This report summarizes the key points raised and suggestions for action proposed during the consultations. vi, 18 p. |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
![]() |
|
https://iris.who.int/handle/10665/375153 |